Evidence map›Paper›PMID 36589039›Full record

ArticleAnnals of Indian Academy of Neurology2022

Clinical Profile of Patients with Leber Hereditary Optic Neuropathy (LHON): An Ambispective Study of North Indian Cohorts.

Vinny Wilson, Prabhjit Kaur, Sofia Singh, Radhika P Ramachandran, Vislavath Jyothi, Karthik V Mahesh, Aastha Takkar, Giriraj Chandak, Ramandeep Singh

Abstract read
In one paragraph

Article in Annals of Indian Academy of Neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vinny WilsonDepartment of Neurology, Armed Forces Medical College, Pune, Maharashtra, India.
Prabhjit KaurDepartment of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sofia SinghDepartment of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Radhika P RamachandranGenomic Research on Complex Diseases Laboratory (GRC Lab), CSIR-Center for Cellular and Molecular Biology (CCMB), Hyderabad, India.
Vislavath JyothiGenomic Research on Complex Diseases Laboratory (GRC Lab), CSIR-Center for Cellular and Molecular Biology (CCMB), Hyderabad, India.
Karthik V MaheshDepartment of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Aastha TakkarDepartment of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Giriraj ChandakGenomic Research on Complex Diseases Laboratory (GRC Lab), CSIR-Center for Cellular and Molecular Biology (CCMB), Hyderabad, India.
Ramandeep SinghDepartment of Ophthalmology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Leber hereditary optic neuropathy (LHON) is a maternally inherited disease resulting in irreversible visual loss usually in patients belonging to the age group of 15-35 years. Clinically, the patients present with sequential or bilateral, painless, progressive visual loss with central (or ceco-central) scotomas. Although the three mutations, namely, G11778A, T14484C, and G3460A contribute to >95% of LHON cases globally, the relative frequency of each mutation varies. Aims and Objectives: We aimed to assess the clinical and genetic profile of patients with mutation-positive LHON at a north Indian tertiary care center. Materials and Methodology: One hundred sixty-one patients (61 prospective and 100 retrospective) presenting with the clinical diagnosis of LHON were screened for the three known mitochondrial mutations (G1178A, G3460A, T14448C). Patients were assessed for detailed clinical, ophthalmological, and neurological examinations. Five milliliter of blood sample was taken to assess the three known mutations using DNA isolation and Sanger sequencing. Results and Discussion: Clinical profile of 83 patients with both positive and negative mutations was analyzed. Twenty-three out of 161 patients (14.3%) tested positive for either of the three mutations. The majority of the patients harbored G11778A mutation (56.52%) followed by T14484C (34.78%) and G3460A (8.69%). No statistical difference could be noted between the clinical profiles of mutation-negative and -positive patients.

Indexed as

Hereditarypainlessprogressivesequentialvisual loss

Identifiers

PMID36589039
PMCPMC9795704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.